Author: admin

The landscape of oncology is currently undergoing a massive transformation as pharmaceutical giants race to develop best-in-class therapeutics for some of the world’s deadliest diseases. Because cancer remains the second leading cause of death globally, the sector has become a primary engine of growth within the life sciences industry. Investors are increasingly focusing on NASDAQ-listed […]

Investors poured into Moderna and Merck on Wednesday after the two pharmaceutical giants announced a major victory in their fight against skin cancer. A late stage clinical trial revealed that a personalized mRNA vaccine called intismeran, used in tandem with Merck’s immunotherapy drug Keytruda, significantly prevented melanoma from returning in high risk patients. The results […]

Key Points The disposition involved 4,884 shares at $131.72 per share, representing a total value of about $643,000. The sale was non-discretionary and was executed to cover tax obligations arising from the vesting of restricted stock units. Following this tax withholding, the insider retains 28,616 shares with a market value of $3.77 million as of […]

The intersection of venture capital and clinical medicine is currently witnessing a profound transformation as artificial intelligence moves from theoretical promise to bedside application. While the overarching goal is a total overhaul of healthcare, investors are finding themselves navigating two very different speeds of innovation. On one hand, there are high-risk moonshots involving humanoid surgical […]